Chitosan nanoparticle encapsulated pentoxifylline improves renal protection and reduces oxidative stress in amikacin induced nephrotoxicity

Bibliographic Information
Authors: Moustafa N.; Abd El-latif M.B.; Farid A.
Journal: Discover Nano
Publisher: Springer
Publication Date: 18 April 2026
Volume / Issue: Volume 21 / Issue 1
Article No.: 128
ISSN: 27319229
DOI: 10.1186/s11671-026-04515-8
Scopus: View on Scopus
Document Type: Article
Access: All Open Access; Gold Open Access; Green Open Access
Authors and Affiliations
Moustafa N., Biotechnology Department, Faculty of Science, Cairo University, Giza, Egypt; Abd El-latif M.B., Environmental Research Department, Theodor Bilharz Research Institute, Giza, Egypt; Farid A., Biotechnology Department, Faculty of Science, Cairo University, Giza, Egypt
Abstract
Amikacin (AMK)-induced nephrotoxicity remains a clinical challenge, necessitating innovative therapeutic strategies. This study developed pentoxifylline-loaded chitosan nanoparticles (PTX-CSNPs) to enhance PTX’s renoprotective effects while minimizing its side effects. PTX-CSNPs were synthesized via ionic gelation, exhibiting high entrapment efficiency (89.53%) and sustained release (87% at 48 h). Characterization revealed spherical nanoparticles (30-50 nm by TEM and 79.05 nm by DLS) with positive zeta potential (+ 32.77 mV), confirmed by FTIR and XRD analyses. In vitro, PTX-CSNPs demonstrated superior antioxidant (98.73% DPPH scavenging), anti-inflammatory (76.46% RBCs membrane stabilization), and anticoagulant activity compared to free PTX. In vivo, AMK-induced nephrotoxic rats treated with PTX-CSNPs showed normalization of renal function biomarkers (BUN, creatinine, uric acid) and oxidative stress markers (MDA, SOD, GSH), alongside reduced inflammatory markers levels outperforming free PTX or CSNPs alone. Histopathology revealed preserved glomerular and tubular architecture. The nanoformulation’s efficacy was attributed to chitosan-mediated targeted delivery and PTX’s anti-inflammatory/antioxidant synergy. These findings highlighted PTX-CSNPs as a promising nanotherapeutic for drug-induced kidney injury, offering enhanced bioavailability and reduced systemic toxicity. © The Author(s) 2026.
Keywords
Chitosan nanoparticles; Nephrotoxicity; Pentoxifylline; Chitosan; Controlled drug delivery; Drug products; Nanoparticles; Oxidative stress; Amikacin; Anti-inflammatories; High entrapment efficiencies; Ionic gelations; Side effect; Synthesised; Therapeutic strategy; Gelation; Targeted drug delivery
Citation Information
Scopus Citations: 0
For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.
The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.
English Website: https://www.tbri.sci.eg/en/
Arabic Website: https://www.tbri.sci.eg/ar/
Prepared and Uploaded by:
Abdalla F. Abdalla
Electronic Portal Unit
